Official fact
A statement directly supported by a current primary source.
Cited beside the claim with version and review date.
Evidence and review status
What we know, what we are testing, and what we cannot promise.
This page shows how Transplant Check separates official facts, plain-language explanations, product hypotheses, and claims that require evidence before publication.
Still neon
Four labels keep claims legible.
A source can support an explanation without proving that a product caused an outcome. The label tells you what kind of statement you are reading.
Plain-language interpretation
A faithful explanation or workflow inference from official facts.
Marked as Transplant Check interpretation.
Product hypothesis
A change the beta is designed to support but has not proven.
Uses “designed to,” “may,” or “we are testing.”
Prohibited outcome claim
A claim that the product changed a clinical, CMS, behavioral, or experience result.
Not published without a suitable reviewed evaluation.
Sources used across the site.
The detailed patient and CMS pages cite these primary sources beside the statements they support. Version and period details appear with the measure explanation.
Links and claim scope checked September 12, 2026; qualified clinical and ESRD quality-measure review remains pending.
Patient and transplant-program guidance
Official patient and program guidance; source links and scope checked September 12, 2026.
CMS and ICH CAHPS measure sources
Official measure, rule, dataset, and survey material; source links and scope checked September 12, 2026.
- CMS: PY 2027 ESRD QIP Program Details
- CMS: Payment Year 2028 ESRD QIP Fact Sheet
- CMS: ESRD Measures Manual, Version 11.2
- CMS: PPPW provider data
- CMS: Dialysis Facility Listing Dataset
- CMS: Dialysis Facilities Quality of Patient Care Rating
- CMS: Dialysis Facilities Patient Survey Star Rating
- CMS: Dialysis Facility Care Compare overview
- CMS: ESRD Clinic Services
- CMS: End-Stage Renal Disease Facilities — Conditions for Coverage
- CMS: CY 2026 ESRD PPS Final Rule Fact Sheet
- ICH CAHPS: Official revised 2026 survey
- ICH CAHPS: Official survey composites
- CMS: In-Center Hemodialysis CAHPS
- CMS: ESRD Network Programs
Primary-source ledger.
These sources support the educational and governance statements on this site. The source owner remains the authority for its guidance, measure, or dataset.
Source links and claim scope checked September 12, 2026. This editorial source check does not represent qualified clinical or ESRD quality-measure review.
01
Measuring Quality — ESRD Quality Incentive Program
Centers for Medicare & Medicaid Services
ESRD QIP measures, domains, and scoring context.
- Version or period
- Current program guidance
- Reviewed
- September 12, 2026
- Freshness
- Review after final rules and at least annually.
02
Kidney Transplant FAQs
Health Resources and Services Administration / OPTN
Referral, evaluation, program criteria, and waitlisting distinctions.
- Version or period
- Patient guidance; page reviewed December 2025
- Reviewed
- September 12, 2026
- Freshness
- Review annually or when OPTN guidance changes.
03
Kidney Transplant
National Institute of Diabetes and Digestive and Kidney Diseases
Transplant as treatment, evaluation, waitlist, medicines, and follow-up.
- Version or period
- Official patient guidance
- Reviewed
- September 12, 2026
- Freshness
- Review annually.
04
Creating Helpful, Reliable, People-First Content
Google Search Central
People-first content, sourcing, expertise, and originality.
- Version or period
- Search guidance
- Reviewed
- September 12, 2026
- Freshness
- Review when guidance changes.
Review has an owner.
A review date is useful only when someone is responsible for the question being reviewed.
These are required review roles for the beta content process. Named qualified reviewers have not yet been recorded, so clinical and ESRD quality-measure publication review remains pending. Transplant Check does not invent credentials or imply that a reviewer is a treating clinician.
- Kidney/transplant clinical reviewer
- Medical accuracy, patient safety, program variation, and treatment-choice neutrality.
- ESRD quality-measure reviewer
- QIP year, measure definitions, scoring boundaries, Care Compare distinctions, and survey interpretation.
- Patient/caregiver reviewer
- Clarity, dignity, usefulness, burden, and whether choices feel non-directive.
- Privacy and security reviewer
- Data collection, analytics, forms, retention, vendors, and protected-health-information boundaries.
- Content owner
- Voice, page intent, source ledger, correction log, and expiry dates.
Product evidence stays separate.
Product hypothesis
We are testing whether clearer next-step information helps people prepare for a care-team conversation.
That is a development question. The site does not claim that the beta improves referral completion, evaluation, waitlisting, PPPW, ICH CAHPS, QIP scores, transplant, hospitalization, survival, or quality of life.
Official fact
CMS measures and transplant-program decisions have their own sources and owners.
CMS calculates its measures. A transplant program confirms its own evaluation and waitlist status. Public education cannot substitute for either source of truth.
Prohibited outcome claims: No generated film, testimonial, workflow description, or product use is evidence of a clinical, CMS, behavioral, or experience outcome. A stronger claim requires a reviewed study design, named outcome, time window, and limitations.
Questions still open.
The beta has questions to answer before it can describe product capability or impact in present tense.
- Can people explain the next stage and named owner after reading the material?
- Does the approach clarify an existing handoff without creating duplicate records?
- What accessibility, language, caregiver, and practical-support needs are missed?
- What evidence would justify a future outcome statement?
Corrections and freshness.
When a material medical or CMS source changes, the public page should show what changed and when.
Material medical or CMS changes receive a public correction date and concise change note. Source links are checked monthly; measure content is reviewed after final rules and at least annually, medical education at least annually, product capabilities at each material release, and privacy whenever a data flow or vendor changes.
Current source-link and claim-scope check: September 12, 2026. Clinical and ESRD quality-measure review remains pending.